摘要
目的:探究肿瘤巨细胞(giant cancer cell,GCC)在口腔鳞癌(oral squamous cell carcinoma,OSCC)组织中的存在情况及其与OSCC临床病理因素的关系。方法:回顾性分析2005年3月至2014年12月天津医科大学肿瘤医院76例OSCC患者的石蜡切片及临床病理资料。H&E染色及Ki-67免疫组织化学染色下观察GCC与普通肿瘤细胞的形态差异,计数GCC细胞,分析其与OSCC临床生物学行为及预后的关系。结果:H&E染色下观察到GCC存在于OSCC中,且Ki-67在GCC中均呈阳性表达。GCC细胞数与临床分期(P=0.02)、组织学分级(P<0.01)、化疗(P=0.01)及局部复发(P=0.02)均显著相关。GCC细胞数在不同性别和年龄的患者中差异不大,且与淋巴结转移、远处转移无关(P>0.05)。GCC数目>3个/HP的OSCC患者预后较差(P<0.05)。结论:GCC可能在OSCC发展过程及耐药中起重要作用,可能是影响OSCC预后的重要因素。
Objective:To detect giant cancer cells in human oral squamous cell carcinoma (OSCC) and elucidate their correlation with OSCC clinicopathological characteristics. Methods:Tumor paraffin sections and clinicopathological information of 76 OSCC cases were collected from Tianjin Medical University Cancer Institute and Hospital. Morphological differences between giant cancer cells and nor-mal-sized cancer cells were observed under H&amp;E staining and Ki-67 immunohistochemistry staining, respectively. The number of giant cancer cells was counted under a microscope (×400). The association between the number of giant cancer cells and the biological be-havior of OSCC was analyzed. Results:Giant cancer cells were observed in OSCC tissues, and these cells were positive for Ki-67 stain-ing. The number of giant cancer cells was closely associated with clinical stage (P=0.02), histological grade (P〈0.01), chemotherapy (P=0.01), and local recurrence (P=0.02). By contrast, the number of giant cancer cells was not associated with sex, age, and lymphatic and distant metastases in OSCC (P〉0.05). Patients with more than 3/HP giant cancer cells retained poor prognosis (P〈0.05). Conclusion:Gi-ant cancer cells may play an important role in the progression, chemotherapeutic resistance, and prognosis of OSCC.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2016年第20期907-912,共6页
Chinese Journal of Clinical Oncology
基金
国家临床重点专科建设项目(编号:2013-544)资助~~
关键词
肿瘤巨细胞
口腔鳞癌
化疗
复发
预后
giant cancer cells
OSCC
chemotherapy
recurrence
prognosis